paxilline has been researched along with simvastatin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aranguiz, P; Avalos, Y; Canales, J; Catalán, M; Chiong, M; Copaja, M; Díaz-Araya, G; Garcia, L; Lavandero, S; Leyton, L; Olmedo, I; Venegas, D; Vivar, R | 1 |
1 other study(ies) available for paxilline and simvastatin
| Article | Year |
|---|---|
Simvastatin disrupts cytoskeleton and decreases cardiac fibroblast adhesion, migration and viability.
Topics: Animals; Blotting, Western; Cell Adhesion; Cell Movement; Cell Survival; Cells, Cultured; Cytoskeleton; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myofibroblasts; Paxillin; Rats; Rats, Sprague-Dawley; Simvastatin; Terpenes; Vinculin | 2012 |